Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:00147119n
Noun Concept
Categories: CYP3A4 inducers, Glycopeptide antibiotics, Eli Lilly and Company brands, Drugboxes which contain changes to watched fields, long volume value
EN
oritavancin  ATC code J01XA05  ATCvet code QJ01XA05  C86H97Cl3N10O26  Chlorobiphenyl-chloroeremomycin
EN
Oritavancin, sold under the brand name Orbactiv among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Wikipedia
Definitions
Relations
Sources
EN
Oritavancin, sold under the brand name Orbactiv among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Wikipedia
Pharmaceutical drug Wikidata
A glycopeptide antibiotic being developed for the treatment of serious Gram-positive infections. Wiktionary
IS A
compound
medicine
bactericide
lipoglycopeptide
MEDICAL CONDITION TREATED
cellulitis
SUBJECT HAS ROLE
antibiotic
protein synthesis inhibitor
Wikipedia
EN
oritavancin
Wikidata
EN
oritavancin
Wiktionary
EN
oritavancin
Wikipedia Redirections
EN
ATC code J01XA05, ATCvet code QJ01XA05, C86H97Cl3N10O26, Kimyrsa, LY333328, Orbactiv, Oritavancin diphosphate
Wikidata Alias
EN
Chlorobiphenyl-chloroeremomycin, LY-333328, Oritavancin

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License